Company / Capital Returned to Shareholders per Share
ANI Pharmaceuticals, Inc. Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.63
FY2025
5-year range
$0.09 / $0.77
FY2021-FY2025
Trend
-18.2%
vs FY2024
Sector context
#27 of 51
Health Care
What the data says
At $0.63, ANI Pharmaceuticals, Inc.'s capital returned to shareholders per share ranks #27 of 51 in the Health Care sector. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2018 to $0.77 in FY2024.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of +37.8%.
Improved from $0.36 to $0.63 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +42.2%
- 5-Year CAGR
- +37.8%
- 10-Year CAGR
- -
Sector benchmark
-76.9% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 18.2% year-over-year.
- Ranks #27 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2024.
- Lowest capital returned to shareholders per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | -18.2% |
| FY2024 | $0.77 | +113.0% |
| FY2023 | $0.36 | +64.9% |
| FY2022 | $0.22 | +157.1% |
| FY2021 | $0.09 | -32.6% |
| FY2020 | $0.13 | +42.6% |
| FY2019 | $0.09 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | -100.0% |
| FY2016 | $0.22 | -99.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026